Molecular Display of the Animal Meta-Venome for Discovery of Novel Therapeutic Peptides

Meng-Hsuan Hsiao,Yang Miao,Zixing Liu,Konstantin Schutze,Nathachit Limjunyawong,Daphne Chun-Che Chien,Wayne Denis Monteiro,Lee-Shin Chu,William Morgenlander,Sahana Jayaraman,Sung-eun Jang,Jeffrey J. Gray,Heng Zhu,Xinzhong Dong,Martin Steinegger,Harry Benjamin Larman
DOI: https://doi.org/10.1101/2024.05.27.595990
2024-05-28
Abstract:Animal venoms, distinguished by their unique structural features and potent bioactivities, represent a vast and relatively untapped reservoir of therapeutic molecules. However, limitations associated with extracting or expressing large numbers of individual venoms and venom-like molecules have precluded their therapeutic evaluation via high throughput screening. Here, we developed an innovative computational approach to design a highly diverse library of animal venoms and "metavenoms". We employed programmable M13 hyperphage display to preserve critical disulfide-bonded structures for highly parallelized single-round biopanning with quantitation via high-throughput DNA sequencing. Our approach led to the discovery of Kunitz type domain containing proteins that target the human itch receptor Mas-related G protein-coupled receptor X4 (MRGPRX4), which plays a crucial role in itch perception. Deep learning-based structural homology mining identified two endogenous human homologs, tissue factor pathway inhibitor (TFPI) and serine peptidase inhibitor, Kunitz type 2 (SPINT2), which exhibit agonist-dependent potentiation of MRGPRX4. Highly multiplexed screening of animal venoms and metavenoms is therefore a promising approach to uncover new drug candidates.
Molecular Biology
What problem does this paper attempt to address?